{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:04:52Z","timestamp":1791389092252,"version":"4.3.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41440-026-02744-z","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:36:51Z","timestamp":1785814611000},"page":"2666-2675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of morning home systolic blood pressure and albuminuria with cardiovascular events in Japanese patients with type 2 diabetes mellitus: The KAMOGAWA-HBP study"],"prefix":"10.1038","volume":"49","author":[{"given":"Tomoya","family":"Katayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Ushigome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanako","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"2744_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jama.286.4.421","volume":"286","author":"HC Gerstein","year":"2001","unstructured":"Gerstein HC, Mann JFE, Yi Q, Dinneen SF, Hoogwerf B, Hall\u00e9 JP, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421\u20136.","journal-title":"JAMA"},{"key":"2744_CR2","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.1016\/j.jcjd.2017.11.004","volume":"42","author":"P McFarlane","year":"2018","unstructured":"McFarlane P, Cherney D, Gilbert RE, Senior P. Chronic Kidney Disease in Diabetes. Can J Diabetes. 2018;42:S201\u20139.","journal-title":"Can J Diabetes"},{"key":"2744_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jash.2018.02.005","volume":"12","author":"E Ushigome","year":"2018","unstructured":"Ushigome E, Oyabu C, Tanaka T, Hasegawa G, Ohnishi M, Tsunoda S, et al. Impact of masked hypertension on diabetic nephropathy in patients with type II diabetes: a KAMOGAWA-HBP study. J Am Soc Hypertens. 2018;12:364\u201371.","journal-title":"J Am Soc Hypertens"},{"key":"2744_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41440-018-0024-6","volume":"41","author":"N Kitagawa","year":"2018","unstructured":"Kitagawa N, Ushigome E, Matsumoto S, Oyabu C, Ushigome H, Yokota I, et al. Prognostic significance of home pulse pressure for progression of diabetic nephropathy: KAMOGAWA-HBP study. Hypertens Res. 2018;41:363\u201371. https:\/\/doi.org\/10.1038\/s41440-018-0024-6.","journal-title":"Hypertens Res"},{"key":"2744_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1161\/HYPERTENSIONAHA.114.04262","volume":"64","author":"K Kario","year":"2014","unstructured":"Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension. 2014;64:989\u201396.","journal-title":"Hypertension"},{"key":"2744_CR6","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1161\/CIR.0000000000000803","volume":"142","author":"D Shimbo","year":"2020","unstructured":"Shimbo D, Artinian NT, Basile JN, Krakoff LR, Margolis KL, Rakotz MK, et al. Self-measured blood pressure monitoring at home: A joint policy statement from the American Heart Association and American Medical Association. Circulation. 2020;142:e42\u201363.","journal-title":"Circulation"},{"key":"2744_CR7","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1161\/01.CIR.0000056521.67546.AA","volume":"107","author":"K Kario","year":"2003","unstructured":"Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Moritani Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation. 2003;107:1401\u20136.","journal-title":"Circulation"},{"key":"2744_CR8","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/ajh\/hpy116","volume":"31","author":"D Kawauchi","year":"2018","unstructured":"Kawauchi D, Hoshide S, Kario K. Morning Home Blood Pressure and Cardiovascular Events in a Japanese General Practice Population Over 80 Years Old: The J-HOP Study. Am J Hypertens. 2018;31:1190\u20136.","journal-title":"Am J Hypertens"},{"key":"2744_CR9","doi-asserted-by":"crossref","unstructured":"Millett ERC, Peters SAE, Woodward M. Sex differences in risk factors for myocardial infarction: Cohort study of UK Biobank participants. BMJ. 2018;363.","DOI":"10.1136\/bmj.k4247"},{"key":"2744_CR10","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/eurheartj\/ehn018","volume":"29","author":"SS Anand","year":"2008","unstructured":"Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al. Risk factors for myocardial infarction in women and men: Insights from the INTERHEART study. Eur Heart J. 2008;29:932\u201340.","journal-title":"Eur Heart J"},{"key":"2744_CR11","doi-asserted-by":"crossref","unstructured":"Kitagawa N, Ushigome E, Tanaka T, Hasegawa G, Nakamura N, Ohnishi M, et al. Isolated high home systolic blood pressure in patients with type 2 diabetes is a prognostic factor for the development of diabetic nephropathy: KAMOGAWA-HBP study. Diabetes Res Clin Pract. 2019;158.","DOI":"10.1016\/j.diabres.2019.107920"},{"key":"2744_CR12","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/hr.2011.128","volume":"34","author":"E Ushigome","year":"2011","unstructured":"Ushigome E, Fukui M, Hamaguchi M, Senmaru T, Sakabe K, Tanaka M, et al. The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus. Hypertens Res. 2011;34:1271\u20135.","journal-title":"Hypertens Res"},{"key":"2744_CR13","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073\u201381.","journal-title":"Lancet"},{"key":"2744_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cmet.2008.03.010","volume":"7","author":"C Iadecola","year":"2008","unstructured":"Iadecola C, Davisson RL. Hypertension and Cerebrovascular Dysfunction. Cell Metab. 2008;7:476\u201384.","journal-title":"Cell Metab"},{"key":"2744_CR15","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, et al. Vascular Contributions to Cognitive Impairment and Dementia. Stroke. 2011;42:2672\u2013713.","journal-title":"Stroke"},{"key":"2744_CR16","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2018;49:e46\u2013e110.","journal-title":"Stroke"},{"key":"2744_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41440-020-00584-z","volume":"44","author":"E Ushigome","year":"2021","unstructured":"Ushigome E, Kitagawa N, Kitagawa N, Tanaka T, Hasegawa G, Ohnishi M, et al. Predictive power of home blood pressure measurement for cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study. Hypertens Res. 2021;44:348\u201354.","journal-title":"Hypertens Res"},{"key":"2744_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","volume":"63","author":"AI Adler","year":"2003","unstructured":"Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64. Kidney Int. 2003;63:225\u201332.","journal-title":"Kidney Int"},{"key":"2744_CR19","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117\u201328.","journal-title":"N Engl J Med"},{"key":"2744_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, De Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377:644\u201357.","journal-title":"N Engl J Med"},{"key":"2744_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","volume":"393","author":"TA Zelniker","year":"2019","unstructured":"Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2019;393:31\u20139.","journal-title":"Lancet"},{"key":"2744_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:311\u201322.","journal-title":"N Engl J Med"},{"key":"2744_CR23","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375:1834\u201344.","journal-title":"N Engl J Med"},{"key":"2744_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019;394:121\u201330.","journal-title":"Lancet"},{"key":"2744_CR25","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/jch.14555","volume":"24","author":"K Kario","year":"2022","unstructured":"Kario K, Wang JG, Chia YC, Turana Y, Sukonthasarn A, Shin J, et al. The HOPE Asia Network 2022 update consensus statement on morning hypertension management in Asia. J Clin Hypertens. 2022;24:1112\u201320.","journal-title":"J Clin Hypertens"},{"key":"2744_CR26","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1038\/s41440-023-01397-6","volume":"46","author":"K Kario","year":"2023","unstructured":"Kario K, Chia YC, Sukonthasarn A, Turana Y, Shin J, Chen CH, et al. Home blood pressure-centered approach\u2014from digital health to medical practice: HOPE Asia Network consensus statement. Hypertens Res. 2023;46:2303\u201320.","journal-title":"Hypertens Res"},{"key":"2744_CR27","first-page":"1473","volume":"42","author":"K Kario","year":"2019","unstructured":"Kario K. Key points of the 2019 Japanese Society of Hypertension Guidelines. Hypertens Res. 2019;42:1473\u20137.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02744-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02744-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02744-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:02:44Z","timestamp":1791151364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02744-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02744-z","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.U., N.N., H.O., M.H., and M.F. have received research grants and support from. AstraZeneca plc, Astellas Pharma Inc., Bristol-Myers Squibb K.K., Daiichi Sankyo Co., Ltd., Eli Lilly Japan K.K., Kyowa Kirin Co., Ltd., Kowa Co., Ltd., Kissei Pharmaceutical Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Corp., Novo Nordisk Pharma Ltd., Nippon Chemiphar Co., Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Sanofi K.K., Taisho Toyama. Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and TERUMO Corp. The remaining authors declare no conflicts of interest. The sponsors had no role in the study design; in the collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to submit the article for publication. The authors, their families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entities related to the subject of this article. Furthermore, although the authors are affiliated with a department that receives financial support from pharmaceutical companies, they received no specific funding for this study and declare that their departmental affiliation did not influence the study. The authors also affirm their full adherence to all journal policies regarding the sharing of data and materials.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}